Navigation Links
Activplant Corporation Announces Global Agreement with GlaxoSmithKline
Date:2/10/2009

Industry Leaders Team up to Drive Performance Improvements World Wide

LONDON, Ontario, Feb. 10 /PRNewswire/ -- Activplant Corporation (www.activplant.com) announced today that GlaxoSmithKline PLC (GSK) has signed a global framework agreement naming Activplant as a recommended business intelligence solution for their world wide manufacturing sites.

The agreement comes after a successful implementation where GSK experienced the ease of use that empowers operators, engineers and management to positively affect their OEE, and consequently, their production costs. Activplant's Throughput Analyzer software product is currently implemented within key GSK facilities in North America and the UK.

"Once we saw how quickly Activplant's Throughput Analyzer could be implemented and drive results in our facility in North Carolina, we felt that it made sense to negotiate a global framework agreement to reduce complexity where our facilities wish to consider implementing OEE projects," said Julian Ward, GSK's application champion. "Over the next 3 months our aim is to achieve a 5% improvement in OEE on the lines running Throughput Analyzer and, with what we have seen to date, we feel we'll improve throughput and efficiencies across all lines where we implement the solution."

"Today's global manufacturing landscape is becoming increasingly competitive and complex. It is critical for manufacturers to arm themselves with real-time operations intelligence facilitating improved decision making and driving a reduction in operating costs," states Activplant President, Drew Forret. "We are thrilled to add GSK as a valued business partner. They are a recognized leader in the Pharmaceutical and Consumer Healthcare sectors, both of which have played an important role in Activplant's continued growth strategy."

Activplant Corporation- an enterprise manufacturing intelligence market leader, Activplant's solutions have set the standard in operational excellence within the world's largest and most admired manufacturers. Aimed at high-volume, high-automation plants, Activplant's technology consolidates plant floor data into relevant real-time and historical intelligence, enabling productivity gains through better decision making. With Activplant solutions, manufacturers can focus on the key issues in their facilities and thereby improve throughput, product quality, and operating margins. Activplant is a privately held company based in London, Ontario. For more information please visit www.activplant.com .

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com


'/>"/>
SOURCE Activplant Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Clarion ... and safety labels , has been featured in the National Electrical Manufacturers ... eiXtra e-newsletter provides electroindustry professionals with manufacturer, regulatory, and standardization news. The publication ...
(Date:5/24/2016)... ... , ... Since 1946, the doctors and staff at Clifton Dental Associates have ... arrives at the office, the staff will make them feel welcome and comfortable. Drs. ... a complete dental treatment plan that is unique to each smile. , Dr. Kayne ...
(Date:5/24/2016)... ... May 24, 2016 , ... PhysicianOne Urgent Care, advocators in ... tick bites and how to avoid being bitten this spring. , The official ... , Ticks, small spider-like insects, are known for attaching themselves to their prey while ...
(Date:5/24/2016)... ... May 24, 2016 , ... Today ... module. The cutting-edge feature provides end users with an embedded, real time ... intelligence solution and its analytics engine. , This powerful addition to ...
(Date:5/24/2016)... TN (PRWEB) , ... May 24, 2016 , ... ... vitamin alkaline water, a revolutionary new beverage for pregnant women to prevent morning ... prenatal vitamins and alkaline minerals with the look and taste of water. , ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... COUNTY, Calif. , May 19, 2016 /PRNewswire/ ... two thirds of the world lacks basic diagnostic ... procedures in the United States ... privileged to such technology. In fact, the WHO ... at risk of avoidable or treatable death, simply ...
(Date:5/19/2016)... -- According to a new market research report "Sunitinib ... Germany , France , U.K., ... Japan )", published by MarketsandMarkets, The market is projected ... 13.9% from 2016 to 2021.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ... spread through 26 Pages and in-depth TOC on "Sunitinib ...
(Date:5/19/2016)... , The data will be presented in ... The conclusions of the study point to a ... 90% of the m presenting duration ... of the patients had clinical benefit.     ... study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed ...
Breaking Medicine Technology: